Aim & Scope
Clinical Case Reports and Trails (ISSN: 2836-2217) is an international, Open Access publisher of peer-reviewed journals encompassing a broad spectrum of scientific research and technological disciplines.
Clinical Case Reports and Trails (ISSN: 2836-2217) is originated with a rigid commitment of serving the scientific and research community by inviting innovations and a vision to encourage the existing scientists, experts and young scientists to enlighten the common society, encompassing a broad spectrum of scientific research and technological disciplines.
Clinical Case Reports and Trails (ISSN: 2836-2217) is an open access, single-blinded, peer-reviewed medical journal, publish original research articles, review papers, clinical studies, case reports, editorials, and perspectives etc. It seeks support from individuals, institutes, libraries, universities, funding agencies, and others.
Clinical Case Reports and Trails (ISSN: 2836-2217) deals with the disorders and complications that are related to assisted reproductive technologies, and clinical case-based interventions.
The current research in Clinical Case Reports and Trails (ISSN: 2836-2217) involves in the development of new techniques to minimize these ailments and provides knowledge for researchers, practitioners and even for common people.
Clinical Case Reports and Trails (ISSN: 2836-2217) accepts the articles in the fields of: Case Report, Case Series, Rare Diseases, Novel Treatment Approaches, Unexpected Drug Reactions, Unusual Disease Presentations, Differential Diagnosis, Disease Progression, Clinical Decision-Making, Diagnostic Challenges, Randomized Controlled Trial (RCT), Double-Blind Study, Placebo-Controlled Trial, Observational Study, Cohort Study, Pharmacokinetics, Pharmacodynamics, Drug-Drug Interactions, Dose-Response Relationship, Biomarker-Guided Therapy, Oncology Clinical Trials, Cardiovascular Clinical Trials, Infectious Disease Trials, Neurology Clinical Trials, Endocrinology Clinical Trials, Rare Disease Clinical Trials, Regenerative Medicine Trials, Good Clinical Practice (GCP), Institutional Review Board (IRB), Ethical Considerations in Trials, Clinical Trial Registration, FDA & EMA Regulations, Data Safety Monitoring Board (DSMB), Post-Marketing Surveillance, Survival Analysis, Meta-Analysis in Clinical Trials, Systematic Reviews, Patient-Reported Outcomes (PROs), Real-World Evidence (RWE), Longitudinal Data Analysis.
Authors can contribute their valuable submission through online and/or to info@mediresonline.org
Case Report: A Case Report is a detailed account of the clinical presentation, diagnosis, treatment, and follow-up of a single patient or a small group of patients. It highlights rare, unusual, or novel medical conditions, therapeutic approaches, or complications, contributing to medical knowledge and clinical practice.
Case Series: A case series is a descriptive study reporting on a group of patients with a similar diagnosis or treatment, documenting their clinical characteristics, outcomes, and patterns. It helps identify trends, generate hypotheses, and guide further research but lacks a control group for comparison.
Rare Diseases: Rare diseases are medical conditions that affect a small percentage of the population, often defined as fewer than 1 in 2,000 individuals. They are frequently chronic, severe, and may be life-threatening, often with limited treatment options and complex diagnostic challenges.
Novel Treatment Approaches: Innovative or newly developed medical interventions designed to prevent, manage, or cure diseases. These approaches often involve advanced technologies, experimental drugs, or unique therapeutic strategies aimed at improving patient outcomes beyond conventional treatments.
Unexpected Drug Reactions: Adverse effects of a medication that are not anticipated based on its known pharmacological profile, dosage, or documented side effects. These reactions may be rare, severe, or occur in specific individuals due to unique biological or genetic factors.
Unusual Disease Presentations: Unusual Disease Presentations refer to medical conditions that manifest with atypical, rare, or unexpected signs and symptoms, differing from the classical or well-known clinical patterns. These presentations can complicate diagnosis and require careful evaluation to identify the underlying disease.
Differential Diagnosis: The systematic process by which a clinician distinguishes a particular disease or condition from others presenting with similar signs and symptoms. It involves evaluating patient history, physical examination, and diagnostic tests to identify the most probable cause of the clinical presentation.
Disease Progression: Disease Progression refers to the natural course by which a disease advances in severity or spreads over time, often leading to worsening symptoms, complications, or organ dysfunction. It encompasses the stages from onset through development to potential recovery or terminal outcomes.
Clinical Decision-Making: Clinical Decision-Making is the process by which healthcare professionals assess patient information, evaluate possible interventions, and choose the most appropriate course of action to achieve optimal patient outcomes. It integrates clinical knowledge, evidence-based guidelines, and patient preferences.
Diagnostic Challenges: Diagnostic Challenges refer to the difficulties or complexities encountered by healthcare professionals in accurately identifying a disease or medical condition. These challenges may arise due to atypical symptoms, overlapping clinical presentations, limited diagnostic tools, or variability in patient responses, making timely and precise diagnosis difficult.
